Detalhe da pesquisa
1.
An updated systematic review and meta-analysis about the safety and efficacy of infliximab biosimilar, CT-P13, for patients with inflammatory bowel disease.
Int J Colorectal Dis;
34(10): 1633-1652, 2019 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31492986